Higher luteal progesterone is associated with low levels of premenstrual aggressive behavior and fatigue

Biological Psychology

Volumn 91, Issue 3, 2012, Pages 376-382

  Ziomkiewicz, A ^a   Pawlowski, B ^b   Ellison, P T ^c   Lipson, S F ^c   Thune, I ^d   Jasienska, G ^e  

^a INSTITUTE OF ANTHROPOLOGY   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

^c HARVARD UNIVERSITY   (United States)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Luteal phase; Mood symptoms; PMS; Progesterone

Indexed keywords

PROGESTERONE;

ADULT; AGGRESSION; ANGER; ARTICLE; CORRELATION ANALYSIS; FATIGUE; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; LACRIMATION; LONELINESS; LUTEAL PHASE; MOOD CHANGE; NORMAL HUMAN; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVA LEVEL;

ADULT; AFFECT; AGGRESSION; FATIGUE; FEMALE; HUMANS; LUTEAL PHASE; PREMENSTRUAL SYNDROME; PROGESTERONE; SALIVA;

EID: 84866978813     PISSN: 03010511     EISSN: 18736246     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2012.08.001     Document Type: Article

References (35)

1. Adamopoulos D.A., Loraine J.A., Lunn S.F., Coppen A.J., Daly R.J. Endocrine profiles in premenstrual tension. Clinical Endocrinology 1972, 1(3):283-292.
2. American College of Obstetricians and Gynecologists (ACOG), 2000. Premenstrual syndrome. ACOG practice bulletin no. 15 or International Journal of Gynecology & Obstetrics 95, 183-191.
3. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, American Psychiatric Association, Washington, DC, p. 715. 4th edition.
4. A modulators. Psychoneuroendocrinology 2009, 34(8):1121-1132.
5. Bäckström T., Andreen L., Birzniece V., Björn I., Johansson I.-M., Nordenstam-Haghjo M., Nyberg S., Sundström-Poromaa I., Wahlström G., Wang M. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 2003, 17(5):325-342.
6. Bäckström T., Carstensen H. Estrogen and progesterone in plasma in relation to premenstrual tension. Journal of Steroid Biochemistry 1974, 5(3):257-260.
7. Bäckström T., Wide L., Sodergaord R., Carstensen H. FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase. Journal of Steroid Biochemistry 1976, 7(6-7):473-476.
8. Björn I., Sundström-Poromaa I., Bixo M., Nyberg S., Bäckström G., Bäckström T. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy. Journal of Clinical Endocrinology and Metabolism 2003, 88(5):2026-2030.
9. Campagne D.M., Campagne G. The premenstrual syndrome revisited. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2007, 130(1):4-17.
10. Campbell E.M., Peterkin D., O'grady K., Sanson-Fisher R. Premenstrual symptoms in general practice patients: prevalence and treatment. Journal of Reproductive Medicine 1997, 42(10):637-646.
11. Dennerstein L., Spencer-Gardner C., Brown J.B., Smith M.A., Burrows G.D. Premenstrual tension-hormonal profiles. Journal of Psychosomatic Obstetrics and Gynaecology 1984, 3(1):37-51.
12. Dennerstein L., Spencer-Gardner C., Gotts G., Brown J.B., Smith M.A., Burrows G.D. Progesterone and the premenstrual syndrome: a double blind crossover trial. British Medical Journal 1985, 290(6482):1617-1621.
13. Eriksson E., Sundblad Ch., Lisjö P., Modigh K., Björn A. Serum levels of androgens are higher in women with premenstrual irritability and dysphoria than in controls. Psychoneuroendocrinology 1992, 17(2-3):195-204.
14. Gailliot M.T., Hildebrandt B., Eckel L.A., Baumeister R.F. A theory of limited metabolic energy and premenstrual syndrome symptoms: increased metabolic demands during the luteal phase divert metabolic resources from and impair self-control. Review of General Psychology 2010, 14(3):269-282.
15. Halbreich U., Endicott J., Goldstein S., Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatrica Scandinavica 1986, 74(6):576-586.
16. Halbreich U., Bäckström T., Eriksson E., O'Brien S., Calil H., Ceskova E., Dennerstein L., Douki S., Freeman E., Genazzani A., et al. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecological Endocrinology 2007, 23(3):123-130.
17. Hammarback S., Bäckström T. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo. Acta Obstetricia et Gynecologica Scandinavica 1988, 67(2):159-166.
18. Hammarback S., Damber J.E., Bäckström T. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. Journal of Clinical Endocrinology and Metabolism 1989, 68(1):125-130.
19. Hammarback S., Ekholm U.B., Bäckström T. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinologica (Copenh) 1991, 125(2):132-137.
20. Hylan T.R., Sundell K., Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. Journal of Women's Health & Gender-Based Medicine 1999, 8(8):1043-1052.
21. Jasienska G., Jasienski M. Inter-population, inter-individual, inter-cycle, and intra-cycle natural variation in progesterone levels: a quantitative assessment and implications for population studies. American Journal of Human Biology 2008, 20(1):35-42.
22. Jasienska G., Ziomkiewicz A., Thune I., Lipson S.F., Ellison P.T. Habitual physical activity and estradiol levels in women of reproductive age. European Journal of Cancer Prevention 2006, 15(5):439-445.
23. Johnson S.R., McChesney C., Bean J.A. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. Journal of Reproductive Medicine 1988, 33(4):340-346.
24. Lipson S.F., Ellison P.T. Comparison of salivary steroid profiles in naturally occurring conception and non-conception cycles. Human Reproduction 1996, 11(10):2090-2096.
25. Munday M.R., Brush M.G., Taylor R.W. Correlations between progesterone, oestradiol and aldosterone levels in the premenstrual syndrome. Clinical Endocrinology 1981, 14(1):1-9.
26. Perez-Lopez F.R., Chedraui P., Perez-Roncero Gonzalo, Lopez-Baena Maria T., Cuadros-Lopez J.L. Premenstrual syndrome and premenstrual dysphoric disorder: symptoms and cluster influences. Open Journal of Psychiatry 2009, 3(1):39-49.
27. Rapkin A.J., Berman S.M., Mandelkern M.A., Silverman D.H.S., Morgan M., London E.D. Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder. Biological Psychiatry 2011, 69(4):374-380.
28. Rapkin A., Chang L.H., Reading A.E. Premenstrual syndrome: a double blind placebo controlled study of treatment with progesterone vaginal suppositories. Journal of Obstetrics and Gynaecology 1987, 7(4):217-220.
29. Rapkin A.J., Morgan M., Goldman L., Brann D.W., Simone D., Mahesh V.B. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Journal of Obstetrics and Gynaecology 1997, 90(5):709-714.
30. Redei E., Freeman E.W. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 1995, 20(3):259-267.
31. Reiber C. An evolutionary model of premenstrual syndrome. Medical Hypotheses 2008, 70(5):1058-1065.
32. Rosenfeld R., Livne D., Nevo O., Dayan L., Milloul V., Lavi S., Jacob G. Hormonal and volume dysregulation in women with premenstrual syndrome. Hypertension 2008, 51(4):1225-1230.
33. Wang M., Seippel L., Purdy R.H., Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. Journal of Clinical Endocrinology and Metabolism 1996, 81(3):1076-1082.
34. Wyatt K., Dimmock P., Jones P., Obhrai M., O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. British Medical Journal 2001, 323(7316):776.
35. Zheng P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Progress in Neurobiology 2009, 89(2):134-152.